Pharmaceutical and biotech executives must manage and optimize Key Opinion Leaders or fall behind in the marketplace
CHAPEL HILL, N.C., November 16, 2010 – Key Opinion Leaders (KOLs) possess a credibility earned through experience and their relationships in their therapeutic area. As a result, KOLs can serve as natural resources for pharmaceutical companies in terms of generating market interest and providing knowledge about specific drugs.
In the ever-changing business environment all life sciences companies face, it is crucial that executives make proper decisions in utilizing and managing the KOLs they work with.
With this in mind, Best Practices, LLC offers its newest thought leader service that provides access to hundreds of best practices in regards to KOL utilization and management. For more information on our services, click here http://www.best-in-class.com/oe4.htm.
Executives must constantly examine their structure and processes to find improvements for working with their KOLs, and Best Practices, LLC’s tools and resources have guided KOL managers for nearly two decades.
This information has been consolidated into the Thought Leadership Excellence Services, a comprehensive package that provides primary research from leading pharmaceutical and biotech companies, as well as case examples of successful practices with KOLs. This service is an essential guide to planning, implementing, and maintaining a productive Thought Leadership function. Click here for more information http://www.best-in-class.com/oe4.htm .
This service contains a variety of data in thought leader areas from how they relate to patient advocacy to how the role they play in preparing the market for new product launches.
This service also provides valuable material for executives of the pharmaceutical organization to ensure superior development and implementation of Thought Leadership strategies. Executives will find numerous resource-related issues addressed, while implementation level managers will be able to create roadmaps and plans for accomplishing their objectives in key areas.
Among the information that can be explored through this collection:
- Annual Membership to the Best Practice Life Sciences Database, with access to more than $35 million in benchmarking research
- Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management
- Patient Advocacy and Professional Organizations: Building Effective Relationships
- New Product Planning for Medical Marketing Structure and Activities to Drive Growth & Profitability
- Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
- Collaborating with Patient Advocacy Groups to Educate the Marketplace
To explore the Thought Leadership Excellence Services in greater detail, download our complimentary research excerpt here http://www.best-in-class.com/oe4.htm, or contact Cameron Tew at 919-767-9246 or via email at firstname.lastname@example.org .
ABOUT BEST PRACTICES, LLC
Best Practices, LLC serves 48 of the world’s 50 top pharmaceutical companies. For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.